“We’ll quickly reveal risk evaluation result on Chinese Valsartan”

Published: 2018-07-16 08:44:00
Updated: 2018-07-16 08:44:51

The Ministry of Food and Drug Safety(MFDS) has already created a bill to evaluate N-Nitrosodimethylamine(NDMA) in antihypertensives with Chinese Valsartan, and was planning to reveal the evaluation result soon. 

The MFDS refuted some media’s reports saying that it would be difficult to find out ...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Most Read News

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.